Sabal Trust’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $33.4M | Buy |
371,212
+12,704
| +4% | +$1.14M | 1.85% | 15 |
|
|
2024
Q4 | $28.6M | Sell |
358,508
-9,676
| -3% | -$838K | 1.65% | 20 |
|
|
2024
Q3 | $33.1M | Sell |
368,184
-947
| -0.3% | -$79.7K | 1.8% | 17 |
|
|
2024
Q2 | $29.1M | Buy |
369,131
+4,713
| +1% | +$386K | 1.73% | 20 |
|
|
2024
Q1 | $31.8M | Buy |
364,418
+9,572
| +3% | +$817K | 1.84% | 17 |
|
|
2023
Q4 | $29.2M | Sell |
354,846
-671
| -0.2% | -$51.1K | 1.8% | 23 |
|
|
2023
Q3 | $27.9M | Buy |
355,517
+383
| +0.1% | +$32.1K | 1.86% | 22 |
|
|
2023
Q2 | $31.3M | Buy |
355,134
+6,981
| +2% | +$601K | 1.99% | 19 |
|
|
2023
Q1 | $28.1M | Buy |
348,153
+25,043
| +8% | +$2.04M | 1.96% | 24 |
|
|
2022
Q4 | $25.1M | Sell |
323,110
-2,431
| -0.7% | -$197K | 1.71% | 31 |
|
|
2022
Q3 | $26.3M | Buy |
325,541
+13,135
| +4% | +$1.18M | 1.99% | 22 |
|
|
2022
Q2 | $28M | Buy |
312,406
+7,605
| +2% | +$771K | 2.01% | 22 |
|
|
2022
Q1 | $33.8M | Buy |
304,801
+7,811
| +3% | +$825K | 2.34% | 16 |
|
|
2021
Q4 | $30.7M | Buy |
296,990
+10,927
| +4% | +$1.27M | 1.95% | 25 |
|
|
2021
Q3 | $35.9M | Buy |
286,063
+2,536
| +0.9% | +$328K | 2.57% | 11 |
|
|
2021
Q2 | $35.2M | Buy |
283,527
+1,852
| +0.7% | +$233K | 2.54% | 9 |
|
|
2021
Q1 | $33.3M | Buy |
281,675
+4,025
| +1% | +$472K | 2.47% | 11 |
|
|
2020
Q4 | $32.5M | Sell |
277,650
-1,798
| -0.6% | -$198K | 2.62% | 6 |
|
|
2020
Q3 | $29M | Sell |
279,448
-10,002
| -3% | -$1M | 2.53% | 14 |
|
|
2020
Q2 | $26.5M | Buy |
289,450
+2,037
| +0.7% | +$195K | 2.48% | 16 |
|
|
2020
Q1 | $25.9M | Sell |
287,413
-20,672
| -7% | -$2.2M | 2.91% | 13 |
|
|
2019
Q4 | $35M | Sell |
308,085
-4,016
| -1% | -$441K | 2.77% | 4 |
|
|
2019
Q3 | $33.9M | Buy |
+312,101
| New | +$32.6M | 2.73% | 3 |
|
|
2019
Q2 | – | Sell |
-306,562
| Closed | -$27.9M | – | 138 |
|
|
2019
Q1 | $27.9M | Buy |
+306,562
| New | +$27.4M | 2.48% | 16 |
|
|
2018
Q4 | – | Sell |
-320,481
| Closed | -$31.5M | – | 145 |
|
|
2018
Q3 | $31.5M | Buy |
320,481
+631
| +0.2% | +$58.3K | 2.79% | 6 |
|
|
2018
Q2 | $27.4M | Buy |
319,850
+5,674
| +2% | +$474K | 2.61% | 12 |
|
|
2018
Q1 | $25.2M | Buy |
+314,176
| New | +$25.9M | 2.41% | 19 |
|
|
2017
Q4 | – | Sell |
-277,741
| Closed | -$21.6M | – | 137 |
|
|
2017
Q3 | $21.6M | Buy |
+277,741
| New | +$23.1M | 2.16% | 31 |
|
Other funds holding MDT
Sabal Trust's MDT Position: Q1 2025 in Review
Sabal Trust increased its Medtronic (MDT) stake by 3.5% in Q1 2025, buying an estimated $1.14M and bringing the position to 371,212 shares worth $33.4M. The position accounts for 1.85% of the portfolio, ranked #15.
Sabal Trust first reported a position in MDT in Q3 2017 and has held it in 28 quarters since. The position peaked at $35.9M in Q3 2021. 2,171 funds tracked by Wall St. Rank hold MDT as of Q1 2025.
- Sabal Trust held 371,212 shares of Medtronic worth $33.4M as of Q1 2025.
- Sabal Trust bought 12,704 Medtronic shares in Q1 2025, an estimated $1.14M.
- Medtronic made up 1.85% of Sabal Trust's portfolio in Q1 2025, its #15 holding.
- Sabal Trust first reported a position in Medtronic in Q3 2017 and has held it in 28 quarters since.
- Sabal Trust's Medtronic position peaked at $35.9M in Q3 2021.
- 2,171 funds tracked by Wall St. Rank held Medtronic as of Q1 2025.
Based on Sabal Trust's 13F filing for Q1 2025, filed 23 Apr 2025.